WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-5.50 Cr | ₹-5.50 Cr | ₹-5.63 Cr | ₹-5.63 Cr | ₹-3.36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WANBURY ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-5.50 Cr |
Mar2023 | ₹-5.50 Cr |
Mar2022 | ₹-5.63 Cr |
Mar2021 | ₹-5.63 Cr |
Mar2020 | ₹-3.36 Cr |
How is Deferred Tax Assets / Liabilities of WANBURY Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.50 Cr | Negative | |
Mar2023 | ₹-5.50 Cr | Negative | |
Mar2022 | ₹-5.63 Cr | Negative | |
Mar2021 | ₹-5.63 Cr | Negative | |
Mar2020 | ₹-3.36 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹822.5 Cr | -2.3% | -7.8% | 29.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -2.3% |
-7.8% |
29.6% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses